Attention deficit hyperactivity disorder stimulant treatments linked to low bone density

Written by Alice Weatherston

New research by scientists at Weill Cornell Medical College (NY, USA) has revealed an association between common prescription drugs for attention deficit hyperactivity disorder (ADHD) and low bone density. The findings highlight the need to monitor bone health of children prescribed these medications given further links between low childhood bone density and later life osteoporosis. The results were presented recently at the annual meeting of the Endocrine Society (April 1–4 2016; MA, USA). Describing the background to the study, lead author Alexis Feuer (Weill Cornell Medical College) explained: “We see many kids in our practice who are taking stimulants and...

To view the full article, please register now for access

It's completely free